Search - tctmd.com

Displaying 241 - 258 of 258

Sort: Relevancy | Date

News Daily News

TARGET-CABG Published: Waiting Period to CABG Flexible Per Platelet Function Test

Yael L. Maxwell

March 15, 2012

News Daily News

Paper Sparks Renewed Discussion on Appropriate Use of PCI

Yael L. Maxwell

February 08, 2012

News Industry News

Polymer-free drug eluting stents result in lower in-stent late loss

November 10, 2011

News Industry News

BIOTRONIK Announces Positive Results for Pantera Lux Paclitaxel Releasing Balloon

November 09, 2011

News Conference News

TAVR: Incorporating Techniques into Daily Practice

November 07, 2011

News Daily News

Challenging Cases, Enhanced Poster Presentations Increase Access, Educational Opportunities

October 31, 2011

News Daily News

FDA, CMS Parallel Review Aims to Speed Access to Innovative Technologies

L.A. McKeown

October 14, 2011

News Industry News

NIH Awards $84 Million Grant to NYU Langone Medical Center and Partnering Institutions for First-of-Its-Kind Comparative Effectiveness ISCHEMIA Clinical Trial

August 01, 2011

News Daily News

Robot-Assisted PCI Shows Promise in Early Clinical Experience

Caitlin E. Cox

April 29, 2011

News Daily News

GRAVITAS Published: No Benefit from High-Dose Clopidogrel in Poor Responders

L.A. McKeown

March 15, 2011

Video

» Interview

Three-Year Outcomes of the Randomized SCOPE I Trial Comparing the ACURATE Neo Versus the SAPIEN 3 Transcatheter Heart Valve System in Patients With Symptomatic Severe Aortic Stenosis

September 18, 2022

Video

» Interview

SCOPE II: A Randomized Trial of Two Self-expanding TAVR Bioprostheses

October 16, 2020

Video

Lessons from the SCOPE I Study and the ACURATE neo2 Body of Evidence

November 7, 2019

Partner Content

Transforming DCB Strategy: Sirolimus-Coated Balloon With Nanolute Technology - Concept Medical

November 5, 2019

Partner Content

Future and Scope of Sirolimus-Coated Balloon in Peripheral Vascular Treatment - Concept Medical

November 5, 2019

Partner Content

ACURATE neo, LOTUS Edge, and Sentinel CPS: Advancing Safety for TAVR Patients - Boston Scientific

November 4, 2019

Partner Content

Ability to Treat Diabetic Patients: With a Novel Combined DES and DCB in a Single Platform - Concept Medical

November 4, 2019

Video

» Interview

Dr. C. Michael Gibson Talks With Dr. Jonas Lanz About SCOPE I: A Randomized Trial of the ACURATE Neo vs. the SAPIEN 3 Bioprosthesis in Patients With Severe Aortic Stenosis

September 26, 2019

Advertisement

TARGET-CABG Published: Waiting Period to CABG Flexible Per Platelet Function Test

Paper Sparks Renewed Discussion on Appropriate Use of PCI

Polymer-free drug eluting stents result in lower in-stent late loss

BIOTRONIK Announces Positive Results for Pantera Lux Paclitaxel Releasing Balloon

TAVR: Incorporating Techniques into Daily Practice

Challenging Cases, Enhanced Poster Presentations Increase Access, Educational Opportunities

FDA, CMS Parallel Review Aims to Speed Access to Innovative Technologies

NIH Awards $84 Million Grant to NYU Langone Medical Center and Partnering Institutions for First-of-Its-Kind Comparative Effectiveness ISCHEMIA Clinical Trial

Robot-Assisted PCI Shows Promise in Early Clinical Experience

GRAVITAS Published: No Benefit from High-Dose Clopidogrel in Poor Responders

Three-Year Outcomes of the Randomized SCOPE I Trial Comparing the ACURATE Neo Versus the SAPIEN 3 Transcatheter Heart Valve System in Patients With Symptomatic Severe Aortic Stenosis

SCOPE II: A Randomized Trial of Two Self-expanding TAVR Bioprostheses

Lessons from the SCOPE I Study and the ACURATE neo2 Body of Evidence

Transforming DCB Strategy: Sirolimus-Coated Balloon With Nanolute Technology - Concept Medical

Future and Scope of Sirolimus-Coated Balloon in Peripheral Vascular Treatment - Concept Medical

ACURATE neo, LOTUS Edge, and Sentinel CPS: Advancing Safety for TAVR Patients - Boston Scientific

Ability to Treat Diabetic Patients: With a Novel Combined DES and DCB in a Single Platform - Concept Medical

Dr. C. Michael Gibson Talks With Dr. Jonas Lanz About SCOPE I: A Randomized Trial of the ACURATE Neo vs. the SAPIEN 3 Bioprosthesis in Patients With Severe Aortic Stenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content